nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—EPHB2—brainstem—intracranial aneurysm	0.00916	0.0218	CbGeAlD
Dasatinib—SRC—artery—intracranial aneurysm	0.00881	0.021	CbGeAlD
Dasatinib—STAT5B—brainstem—intracranial aneurysm	0.00831	0.0198	CbGeAlD
Dasatinib—MYT1—cerebellum—intracranial aneurysm	0.00825	0.0196	CbGeAlD
Dasatinib—PKMYT1—medulla oblongata—intracranial aneurysm	0.0067	0.016	CbGeAlD
Dasatinib—MYT1—brain—intracranial aneurysm	0.0067	0.016	CbGeAlD
Dasatinib—EPHB3—brainstem—intracranial aneurysm	0.00604	0.0144	CbGeAlD
Dasatinib—STK35—brainstem—intracranial aneurysm	0.00566	0.0135	CbGeAlD
Dasatinib—EPHB1—cerebellum—intracranial aneurysm	0.0055	0.0131	CbGeAlD
Dasatinib—EPHA4—brainstem—intracranial aneurysm	0.00505	0.012	CbGeAlD
Dasatinib—SIK3—midbrain—intracranial aneurysm	0.00476	0.0113	CbGeAlD
Dasatinib—EPHA5—medulla oblongata—intracranial aneurysm	0.00474	0.0113	CbGeAlD
Dasatinib—PKMYT1—cerebellum—intracranial aneurysm	0.00474	0.0113	CbGeAlD
Dasatinib—MAPK14—brainstem—intracranial aneurysm	0.00465	0.0111	CbGeAlD
Dasatinib—BTK—medulla oblongata—intracranial aneurysm	0.00462	0.011	CbGeAlD
Dasatinib—EPHB1—brain—intracranial aneurysm	0.00447	0.0106	CbGeAlD
Dasatinib—EPHA8—cerebellum—intracranial aneurysm	0.00433	0.0103	CbGeAlD
Dasatinib—EPHA5—midbrain—intracranial aneurysm	0.00433	0.0103	CbGeAlD
Dasatinib—FYN—brainstem—intracranial aneurysm	0.00432	0.0103	CbGeAlD
Dasatinib—TESK1—medulla oblongata—intracranial aneurysm	0.00428	0.0102	CbGeAlD
Dasatinib—STK36—medulla oblongata—intracranial aneurysm	0.00421	0.01	CbGeAlD
Dasatinib—STAT5B—cerebellum—intracranial aneurysm	0.0041	0.00976	CbGeAlD
Dasatinib—SIK2—brain—intracranial aneurysm	0.00395	0.00941	CbGeAlD
Dasatinib—CSK—medulla oblongata—intracranial aneurysm	0.00392	0.00934	CbGeAlD
Dasatinib—TESK1—midbrain—intracranial aneurysm	0.00391	0.00932	CbGeAlD
Dasatinib—HCK—medulla oblongata—intracranial aneurysm	0.00387	0.00922	CbGeAlD
Dasatinib—PKMYT1—brain—intracranial aneurysm	0.00385	0.00917	CbGeAlD
Dasatinib—SIK3—cerebellum—intracranial aneurysm	0.00368	0.00878	CbGeAlD
Dasatinib—EPHB2—brain—intracranial aneurysm	0.00367	0.00874	CbGeAlD
Dasatinib—RIPK2—medulla oblongata—intracranial aneurysm	0.00364	0.00867	CbGeAlD
Dasatinib—STK35—midbrain—intracranial aneurysm	0.00361	0.0086	CbGeAlD
Dasatinib—SRMS—brain—intracranial aneurysm	0.00359	0.00856	CbGeAlD
Dasatinib—CSK—midbrain—intracranial aneurysm	0.00358	0.00854	CbGeAlD
Dasatinib—SIK1—medulla oblongata—intracranial aneurysm	0.00355	0.00847	CbGeAlD
Dasatinib—HCK—midbrain—intracranial aneurysm	0.00354	0.00843	CbGeAlD
Dasatinib—EPHA4—medulla oblongata—intracranial aneurysm	0.00352	0.00838	CbGeAlD
Dasatinib—EPHA8—brain—intracranial aneurysm	0.00352	0.00838	CbGeAlD
Dasatinib—MAP2K5—brainstem—intracranial aneurysm	0.00345	0.00822	CbGeAlD
Dasatinib—ZAK—cerebellum—intracranial aneurysm	0.00342	0.00816	CbGeAlD
Dasatinib—EPHA5—cerebellum—intracranial aneurysm	0.00335	0.00798	CbGeAlD
Dasatinib—STAT5B—brain—intracranial aneurysm	0.00333	0.00793	CbGeAlD
Dasatinib—RIPK2—midbrain—intracranial aneurysm	0.00333	0.00793	CbGeAlD
Dasatinib—BMPR1B—cerebellum—intracranial aneurysm	0.00328	0.00782	CbGeAlD
Dasatinib—TNK2—cerebellum—intracranial aneurysm	0.00322	0.00767	CbGeAlD
Dasatinib—ERBB3—midbrain—intracranial aneurysm	0.00318	0.00759	CbGeAlD
Dasatinib—EPHB4—medulla oblongata—intracranial aneurysm	0.00308	0.00733	CbGeAlD
Dasatinib—EPHA3—brain—intracranial aneurysm	0.00308	0.00733	CbGeAlD
Dasatinib—KIT—brainstem—intracranial aneurysm	0.00306	0.00728	CbGeAlD
Dasatinib—JAK2—medulla oblongata—intracranial aneurysm	0.00305	0.00728	CbGeAlD
Dasatinib—TESK1—cerebellum—intracranial aneurysm	0.00303	0.00721	CbGeAlD
Dasatinib—FYN—medulla oblongata—intracranial aneurysm	0.00301	0.00718	CbGeAlD
Dasatinib—SIK3—brain—intracranial aneurysm	0.00299	0.00713	CbGeAlD
Dasatinib—EPHB3—cerebellum—intracranial aneurysm	0.00298	0.0071	CbGeAlD
Dasatinib—STK36—cerebellum—intracranial aneurysm	0.00298	0.0071	CbGeAlD
Dasatinib—MAP3K3—medulla oblongata—intracranial aneurysm	0.00294	0.00701	CbGeAlD
Dasatinib—MAP4K5—medulla oblongata—intracranial aneurysm	0.00294	0.00701	CbGeAlD
Dasatinib—LIMK2—cerebellum—intracranial aneurysm	0.00288	0.00686	CbGeAlD
Dasatinib—EPHB6—medulla oblongata—intracranial aneurysm	0.00281	0.0067	CbGeAlD
Dasatinib—EPHB4—midbrain—intracranial aneurysm	0.00281	0.0067	CbGeAlD
Dasatinib—STK35—cerebellum—intracranial aneurysm	0.00279	0.00665	CbGeAlD
Dasatinib—ZAK—brain—intracranial aneurysm	0.00278	0.00663	CbGeAlD
Dasatinib—CSK—cerebellum—intracranial aneurysm	0.00277	0.00661	CbGeAlD
Dasatinib—FYN—midbrain—intracranial aneurysm	0.00275	0.00656	CbGeAlD
Dasatinib—EPHA5—brain—intracranial aneurysm	0.00272	0.00648	CbGeAlD
Dasatinib—ABL2—cerebellum—intracranial aneurysm	0.00272	0.00648	CbGeAlD
Dasatinib—YES1—medulla oblongata—intracranial aneurysm	0.00272	0.00648	CbGeAlD
Dasatinib—LYN—brain—intracranial aneurysm	0.00271	0.00645	CbGeAlD
Dasatinib—MAP3K3—midbrain—intracranial aneurysm	0.00269	0.00641	CbGeAlD
Dasatinib—MAP4K5—midbrain—intracranial aneurysm	0.00269	0.00641	CbGeAlD
Dasatinib—MAP3K19—brain—intracranial aneurysm	0.00267	0.00635	CbGeAlD
Dasatinib—BMPR1B—brain—intracranial aneurysm	0.00267	0.00635	CbGeAlD
Dasatinib—ABL1—brainstem—intracranial aneurysm	0.00266	0.00634	CbGeAlD
Dasatinib—BTK—brain—intracranial aneurysm	0.00265	0.00632	CbGeAlD
Dasatinib—TNK2—brain—intracranial aneurysm	0.00261	0.00623	CbGeAlD
Dasatinib—RIPK2—cerebellum—intracranial aneurysm	0.00257	0.00613	CbGeAlD
Dasatinib—EPHB6—midbrain—intracranial aneurysm	0.00257	0.00613	CbGeAlD
Dasatinib—SIK1—cerebellum—intracranial aneurysm	0.00251	0.00599	CbGeAlD
Dasatinib—EPHA4—cerebellum—intracranial aneurysm	0.00249	0.00593	CbGeAlD
Dasatinib—YES1—midbrain—intracranial aneurysm	0.00248	0.00592	CbGeAlD
Dasatinib—ERBB3—cerebellum—intracranial aneurysm	0.00246	0.00587	CbGeAlD
Dasatinib—TESK1—brain—intracranial aneurysm	0.00246	0.00586	CbGeAlD
Dasatinib—MAP3K2—cerebellum—intracranial aneurysm	0.00244	0.00581	CbGeAlD
Dasatinib—STK36—brain—intracranial aneurysm	0.00242	0.00576	CbGeAlD
Dasatinib—EPHB3—brain—intracranial aneurysm	0.00242	0.00576	CbGeAlD
Dasatinib—MAP2K5—medulla oblongata—intracranial aneurysm	0.00241	0.00573	CbGeAlD
Dasatinib—CSF1R—medulla oblongata—intracranial aneurysm	0.00235	0.00559	CbGeAlD
Dasatinib—LIMK2—brain—intracranial aneurysm	0.00234	0.00557	CbGeAlD
Dasatinib—MAPK14—cerebellum—intracranial aneurysm	0.00229	0.00547	CbGeAlD
Dasatinib—STK35—brain—intracranial aneurysm	0.00227	0.0054	CbGeAlD
Dasatinib—CSK—brain—intracranial aneurysm	0.00225	0.00537	CbGeAlD
Dasatinib—HCK—brain—intracranial aneurysm	0.00222	0.0053	CbGeAlD
Dasatinib—ABL2—brain—intracranial aneurysm	0.00221	0.00526	CbGeAlD
Dasatinib—MAP2K5—midbrain—intracranial aneurysm	0.0022	0.00524	CbGeAlD
Dasatinib—EPHB4—cerebellum—intracranial aneurysm	0.00217	0.00518	CbGeAlD
Dasatinib—JAK2—cerebellum—intracranial aneurysm	0.00216	0.00514	CbGeAlD
Dasatinib—CSF1R—midbrain—intracranial aneurysm	0.00215	0.00511	CbGeAlD
Dasatinib—KIT—medulla oblongata—intracranial aneurysm	0.00213	0.00508	CbGeAlD
Dasatinib—FYN—cerebellum—intracranial aneurysm	0.00213	0.00507	CbGeAlD
Dasatinib—RIPK2—brain—intracranial aneurysm	0.00209	0.00498	CbGeAlD
Dasatinib—PDGFRB—medulla oblongata—intracranial aneurysm	0.00208	0.00496	CbGeAlD
Dasatinib—MAP4K5—cerebellum—intracranial aneurysm	0.00208	0.00496	CbGeAlD
Dasatinib—MAP3K3—cerebellum—intracranial aneurysm	0.00208	0.00496	CbGeAlD
Dasatinib—SIK1—brain—intracranial aneurysm	0.00204	0.00486	CbGeAlD
Dasatinib—EPHA4—brain—intracranial aneurysm	0.00202	0.00481	CbGeAlD
Dasatinib—ERBB3—brain—intracranial aneurysm	0.002	0.00477	CbGeAlD
Dasatinib—EPHB6—cerebellum—intracranial aneurysm	0.00199	0.00474	CbGeAlD
Dasatinib—MAP3K2—brain—intracranial aneurysm	0.00198	0.00472	CbGeAlD
Dasatinib—KIT—midbrain—intracranial aneurysm	0.00195	0.00464	CbGeAlD
Dasatinib—YES1—cerebellum—intracranial aneurysm	0.00192	0.00458	CbGeAlD
Dasatinib—PDGFRB—midbrain—intracranial aneurysm	0.0019	0.00453	CbGeAlD
Dasatinib—PDGFRA—cerebellum—intracranial aneurysm	0.00189	0.00449	CbGeAlD
Dasatinib—MAPK14—brain—intracranial aneurysm	0.00186	0.00444	CbGeAlD
Dasatinib—ABL1—medulla oblongata—intracranial aneurysm	0.00186	0.00442	CbGeAlD
Dasatinib—FGR—brain—intracranial aneurysm	0.00186	0.00442	CbGeAlD
Dasatinib—SRC—cerebellum—intracranial aneurysm	0.00185	0.00441	CbGeAlD
Dasatinib—FMO3—brain—intracranial aneurysm	0.00179	0.00427	CbGeAlD
Dasatinib—EPHB4—brain—intracranial aneurysm	0.00177	0.00421	CbGeAlD
Dasatinib—JAK2—brain—intracranial aneurysm	0.00175	0.00418	CbGeAlD
Dasatinib—EPHA2—brain—intracranial aneurysm	0.00173	0.00413	CbGeAlD
Dasatinib—FYN—brain—intracranial aneurysm	0.00173	0.00412	CbGeAlD
Dasatinib—MAP2K5—cerebellum—intracranial aneurysm	0.0017	0.00405	CbGeAlD
Dasatinib—ABL1—midbrain—intracranial aneurysm	0.0017	0.00404	CbGeAlD
Dasatinib—MAP3K3—brain—intracranial aneurysm	0.00169	0.00403	CbGeAlD
Dasatinib—MAP4K5—brain—intracranial aneurysm	0.00169	0.00403	CbGeAlD
Dasatinib—CSF1R—cerebellum—intracranial aneurysm	0.00166	0.00396	CbGeAlD
Dasatinib—EPHB6—brain—intracranial aneurysm	0.00162	0.00385	CbGeAlD
Dasatinib—YES1—brain—intracranial aneurysm	0.00156	0.00372	CbGeAlD
Dasatinib—PDGFRA—brain—intracranial aneurysm	0.00153	0.00365	CbGeAlD
Dasatinib—KIT—cerebellum—intracranial aneurysm	0.00151	0.00359	CbGeAlD
Dasatinib—SRC—brain—intracranial aneurysm	0.0015	0.00358	CbGeAlD
Dasatinib—PDGFRB—cerebellum—intracranial aneurysm	0.00147	0.00351	CbGeAlD
Dasatinib—MAP2K5—brain—intracranial aneurysm	0.00138	0.00329	CbGeAlD
Dasatinib—CSF1R—brain—intracranial aneurysm	0.00135	0.00321	CbGeAlD
Dasatinib—ABL1—cerebellum—intracranial aneurysm	0.00131	0.00313	CbGeAlD
Dasatinib—KIT—brain—intracranial aneurysm	0.00122	0.00292	CbGeAlD
Dasatinib—PDGFRB—brain—intracranial aneurysm	0.0012	0.00285	CbGeAlD
Dasatinib—ABCG2—medulla oblongata—intracranial aneurysm	0.00117	0.00279	CbGeAlD
Dasatinib—CYP1B1—cerebellum—intracranial aneurysm	0.00111	0.00265	CbGeAlD
Dasatinib—ABCG2—midbrain—intracranial aneurysm	0.00107	0.00255	CbGeAlD
Dasatinib—ABL1—brain—intracranial aneurysm	0.00107	0.00254	CbGeAlD
Dasatinib—CYP1B1—brain—intracranial aneurysm	0.000903	0.00215	CbGeAlD
Dasatinib—ABCG2—cerebellum—intracranial aneurysm	0.000827	0.00197	CbGeAlD
Dasatinib—ABCG2—brain—intracranial aneurysm	0.000672	0.0016	CbGeAlD
Dasatinib—CYP1A1—brain—intracranial aneurysm	0.000638	0.00152	CbGeAlD
Dasatinib—ABCB1—medulla oblongata—intracranial aneurysm	0.000577	0.00137	CbGeAlD
Dasatinib—ABCB1—midbrain—intracranial aneurysm	0.000527	0.00126	CbGeAlD
Dasatinib—ABCB1—cerebellum—intracranial aneurysm	0.000408	0.000972	CbGeAlD
Dasatinib—ABCB1—brain—intracranial aneurysm	0.000331	0.00079	CbGeAlD
Dasatinib—CSK—Immune System—AGER—intracranial aneurysm	0.000275	0.000473	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—NCF1—intracranial aneurysm	0.000274	0.000471	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CTSB—intracranial aneurysm	0.000271	0.000467	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—NCF1—intracranial aneurysm	0.00027	0.000465	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CTSK—intracranial aneurysm	0.000267	0.00046	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—AGER—intracranial aneurysm	0.000266	0.000458	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—NCF1—intracranial aneurysm	0.000265	0.000457	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CTSS—intracranial aneurysm	0.000264	0.000455	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—AGER—intracranial aneurysm	0.000264	0.000455	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—EDNRA—intracranial aneurysm	0.000258	0.000445	CbGpPWpGaD
Dasatinib—KIT—Immune System—CTSK—intracranial aneurysm	0.000257	0.000442	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CTSK—intracranial aneurysm	0.000256	0.000442	CbGpPWpGaD
Dasatinib—LCK—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000255	0.00044	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—TIMP1—intracranial aneurysm	0.000254	0.000438	CbGpPWpGaD
Dasatinib—SRC—EGF/EGFR Signaling Pathway—NOS3—intracranial aneurysm	0.000252	0.000434	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—MMP9—intracranial aneurysm	0.00025	0.000431	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—EDNRA—intracranial aneurysm	0.00025	0.000431	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—CTSB—intracranial aneurysm	0.00025	0.00043	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NCF1—intracranial aneurysm	0.000249	0.000429	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CTSK—intracranial aneurysm	0.000243	0.000419	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—CTSB—intracranial aneurysm	0.00024	0.000413	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—NCF1—intracranial aneurysm	0.000239	0.000411	CbGpPWpGaD
Dasatinib—YES1—Immune System—CTSB—intracranial aneurysm	0.000238	0.00041	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CTSS—intracranial aneurysm	0.000238	0.00041	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ASAH1—intracranial aneurysm	0.000237	0.000408	CbGpPWpGaD
Dasatinib—YES1—Immune System—NCF1—intracranial aneurysm	0.000237	0.000408	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—AGER—intracranial aneurysm	0.000236	0.000407	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—AGER—intracranial aneurysm	0.000236	0.000406	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—SLC25A16—intracranial aneurysm	0.000233	0.000402	CbGpPWpGaD
Dasatinib—LYN—Immune System—CTSS—intracranial aneurysm	0.000233	0.000401	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—NOS3—intracranial aneurysm	0.000232	0.0004	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CTSS—intracranial aneurysm	0.000232	0.0004	CbGpPWpGaD
Dasatinib—BTK—Immune System—AGER—intracranial aneurysm	0.00023	0.000396	CbGpPWpGaD
Dasatinib—FYN—Immune System—CTSS—intracranial aneurysm	0.000229	0.000395	CbGpPWpGaD
Dasatinib—SRC—Signaling by SCF-KIT—MMP9—intracranial aneurysm	0.000226	0.000389	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—TIMP1—intracranial aneurysm	0.000225	0.000387	CbGpPWpGaD
Dasatinib—KIT—Disease—CST3—intracranial aneurysm	0.000224	0.000387	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—AGER—intracranial aneurysm	0.000223	0.000384	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CTSB—intracranial aneurysm	0.000221	0.000381	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CTSS—intracranial aneurysm	0.000221	0.000381	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—SLC25A16—intracranial aneurysm	0.00022	0.000379	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CTSK—intracranial aneurysm	0.000219	0.000377	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CTSS—intracranial aneurysm	0.000218	0.000376	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ASAH1—intracranial aneurysm	0.000215	0.000371	CbGpPWpGaD
Dasatinib—YES1—Axon guidance—MMP9—intracranial aneurysm	0.000215	0.00037	CbGpPWpGaD
Dasatinib—LYN—Immune System—CTSK—intracranial aneurysm	0.000214	0.000369	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CTSK—intracranial aneurysm	0.000213	0.000368	CbGpPWpGaD
Dasatinib—LYN—Axon guidance—MMP2—intracranial aneurysm	0.000213	0.000367	CbGpPWpGaD
Dasatinib—KIT—Immune System—CTSB—intracranial aneurysm	0.000213	0.000366	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—CST3—intracranial aneurysm	0.000213	0.000366	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CTSB—intracranial aneurysm	0.000212	0.000366	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—MMP2—intracranial aneurysm	0.000212	0.000365	CbGpPWpGaD
Dasatinib—KIT—Immune System—NCF1—intracranial aneurysm	0.000211	0.000364	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—NCF1—intracranial aneurysm	0.000211	0.000364	CbGpPWpGaD
Dasatinib—FYN—Immune System—CTSK—intracranial aneurysm	0.000211	0.000364	CbGpPWpGaD
Dasatinib—HCK—Immune System—AGER—intracranial aneurysm	0.000211	0.000363	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—MMP2—intracranial aneurysm	0.00021	0.000361	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.000209	0.00036	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—MMP2—intracranial aneurysm	0.000204	0.000351	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CTSK—intracranial aneurysm	0.000203	0.00035	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CTSB—intracranial aneurysm	0.000201	0.000347	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—AGER—intracranial aneurysm	0.000201	0.000346	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CTSK—intracranial aneurysm	0.000201	0.000346	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—NCF1—intracranial aneurysm	0.0002	0.000345	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—MMP2—intracranial aneurysm	0.000199	0.000343	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—AGER—intracranial aneurysm	0.000199	0.000342	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—NCF1—intracranial aneurysm	0.000198	0.000341	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—AGER—intracranial aneurysm	0.000197	0.000339	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—AGER—intracranial aneurysm	0.000196	0.000337	CbGpPWpGaD
Dasatinib—KIT—Disease—NCF1—intracranial aneurysm	0.000195	0.000336	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—AGER—intracranial aneurysm	0.000194	0.000334	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—CST3—intracranial aneurysm	0.000191	0.00033	CbGpPWpGaD
Dasatinib—BLK—Immune System—AGER—intracranial aneurysm	0.000191	0.000329	CbGpPWpGaD
Dasatinib—LCK—Immune System—CTSS—intracranial aneurysm	0.000191	0.000329	CbGpPWpGaD
Dasatinib—FGR—Immune System—AGER—intracranial aneurysm	0.00019	0.000328	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000188	0.000324	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—NOS3—intracranial aneurysm	0.000187	0.000323	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000187	0.000322	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—AGER—intracranial aneurysm	0.000186	0.000321	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NCF1—intracranial aneurysm	0.000185	0.000318	CbGpPWpGaD
Dasatinib—FYN—Disease—CST3—intracranial aneurysm	0.000185	0.000318	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—AGER—intracranial aneurysm	0.000184	0.000317	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CTSB—intracranial aneurysm	0.000181	0.000312	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NCF1—intracranial aneurysm	0.000181	0.000312	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—CCL2—intracranial aneurysm	0.000181	0.000311	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NCF1—intracranial aneurysm	0.00018	0.000311	CbGpPWpGaD
Dasatinib—LYN—Immune System—CTSB—intracranial aneurysm	0.000177	0.000306	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CTSB—intracranial aneurysm	0.000177	0.000304	CbGpPWpGaD
Dasatinib—LYN—Immune System—NCF1—intracranial aneurysm	0.000177	0.000304	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—SLC25A16—intracranial aneurysm	0.000176	0.000303	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NCF1—intracranial aneurysm	0.000176	0.000303	CbGpPWpGaD
Dasatinib—LCK—Immune System—CTSK—intracranial aneurysm	0.000176	0.000303	CbGpPWpGaD
Dasatinib—JAK2—Disease—CST3—intracranial aneurysm	0.000175	0.000302	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—AGER—intracranial aneurysm	0.000175	0.000302	CbGpPWpGaD
Dasatinib—FYN—Immune System—CTSB—intracranial aneurysm	0.000175	0.000301	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NCF1—intracranial aneurysm	0.000174	0.000301	CbGpPWpGaD
Dasatinib—FYN—Immune System—NCF1—intracranial aneurysm	0.000174	0.0003	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—EDNRA—intracranial aneurysm	0.000171	0.000294	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000171	0.000294	CbGpPWpGaD
Dasatinib—SRC—Immune System—CTSS—intracranial aneurysm	0.000169	0.000291	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CTSB—intracranial aneurysm	0.000168	0.00029	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NCF1—intracranial aneurysm	0.000167	0.000288	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NCF1—intracranial aneurysm	0.000166	0.000287	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CTSB—intracranial aneurysm	0.000166	0.000286	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NCF1—intracranial aneurysm	0.000165	0.000285	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—EDNRA—intracranial aneurysm	0.000165	0.000284	CbGpPWpGaD
Dasatinib—CSK—Disease—NOS3—intracranial aneurysm	0.000162	0.000279	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—AGER—intracranial aneurysm	0.000161	0.000278	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—NOS3—intracranial aneurysm	0.000161	0.000278	CbGpPWpGaD
Dasatinib—FYN—Disease—NCF1—intracranial aneurysm	0.00016	0.000277	CbGpPWpGaD
Dasatinib—LYN—Axon guidance—MMP9—intracranial aneurysm	0.00016	0.000276	CbGpPWpGaD
Dasatinib—ABL1—Axon guidance—MMP9—intracranial aneurysm	0.000159	0.000275	CbGpPWpGaD
Dasatinib—FYN—Axon guidance—MMP9—intracranial aneurysm	0.000158	0.000272	CbGpPWpGaD
Dasatinib—STAT5B—Disease—NOS3—intracranial aneurysm	0.000157	0.00027	CbGpPWpGaD
Dasatinib—SRC—Immune System—CTSK—intracranial aneurysm	0.000156	0.000268	CbGpPWpGaD
Dasatinib—SRC—Axon guidance—MMP2—intracranial aneurysm	0.000155	0.000266	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ASAH1—intracranial aneurysm	0.000154	0.000266	CbGpPWpGaD
Dasatinib—LCK—Disease—CST3—intracranial aneurysm	0.000154	0.000265	CbGpPWpGaD
Dasatinib—YES1—Immune System—AGER—intracranial aneurysm	0.000154	0.000265	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—MMP9—intracranial aneurysm	0.000153	0.000264	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NCF1—intracranial aneurysm	0.000153	0.000264	CbGpPWpGaD
Dasatinib—JAK2—Disease—NCF1—intracranial aneurysm	0.000153	0.000263	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—MMP2—intracranial aneurysm	0.000152	0.000262	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—MMP2—intracranial aneurysm	0.000151	0.000261	CbGpPWpGaD
Dasatinib—JAK2—Axon guidance—MMP9—intracranial aneurysm	0.00015	0.000258	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—MMP2—intracranial aneurysm	0.00015	0.000258	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ASAH1—intracranial aneurysm	0.000146	0.000251	CbGpPWpGaD
Dasatinib—LCK—Immune System—CTSB—intracranial aneurysm	0.000145	0.000251	CbGpPWpGaD
Dasatinib—LCK—Immune System—NCF1—intracranial aneurysm	0.000145	0.000249	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000145	0.000249	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—MMP2—intracranial aneurysm	0.000144	0.000248	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—AGER—intracranial aneurysm	0.000143	0.000246	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—MMP2—intracranial aneurysm	0.000142	0.000245	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—SLC25A16—intracranial aneurysm	0.00014	0.000242	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—NOS3—intracranial aneurysm	0.00014	0.000241	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—NOS3—intracranial aneurysm	0.000139	0.00024	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—NOS3—intracranial aneurysm	0.000137	0.000237	CbGpPWpGaD
Dasatinib—KIT—Immune System—AGER—intracranial aneurysm	0.000137	0.000236	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NCF1—intracranial aneurysm	0.000137	0.000236	CbGpPWpGaD
Dasatinib—SRC—Disease—CST3—intracranial aneurysm	0.000136	0.000234	CbGpPWpGaD
Dasatinib—LCK—Disease—NCF1—intracranial aneurysm	0.000134	0.00023	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—NOS3—intracranial aneurysm	0.000132	0.000228	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—NOS3—intracranial aneurysm	0.000131	0.000225	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—AGER—intracranial aneurysm	0.00013	0.000224	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NCF1—intracranial aneurysm	0.000129	0.000223	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—MMP9—intracranial aneurysm	0.000129	0.000223	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—EDNRA—intracranial aneurysm	0.000129	0.000222	CbGpPWpGaD
Dasatinib—SRC—Immune System—CTSB—intracranial aneurysm	0.000129	0.000222	CbGpPWpGaD
Dasatinib—SRC—Immune System—NCF1—intracranial aneurysm	0.000128	0.000221	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—CCL2—intracranial aneurysm	0.000127	0.000219	CbGpPWpGaD
Dasatinib—HCK—Disease—NOS3—intracranial aneurysm	0.000124	0.000214	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—CCL2—intracranial aneurysm	0.000123	0.000212	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—EDNRA—intracranial aneurysm	0.000122	0.000211	CbGpPWpGaD
Dasatinib—SRC—Disease—NCF1—intracranial aneurysm	0.000118	0.000204	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—AGER—intracranial aneurysm	0.000117	0.000202	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NCF1—intracranial aneurysm	0.000117	0.000201	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ASAH1—intracranial aneurysm	0.000116	0.000201	CbGpPWpGaD
Dasatinib—SRC—Axon guidance—MMP9—intracranial aneurysm	0.000116	0.0002	CbGpPWpGaD
Dasatinib—LYN—Immune System—AGER—intracranial aneurysm	0.000115	0.000197	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—NOS3—intracranial aneurysm	0.000114	0.000197	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—MMP9—intracranial aneurysm	0.000114	0.000197	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NCF1—intracranial aneurysm	0.000114	0.000197	CbGpPWpGaD
Dasatinib—ABL1—Immune System—AGER—intracranial aneurysm	0.000114	0.000196	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—MMP9—intracranial aneurysm	0.000114	0.000196	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—NOS3—intracranial aneurysm	0.000113	0.000196	CbGpPWpGaD
Dasatinib—FYN—Immune System—AGER—intracranial aneurysm	0.000113	0.000194	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—MMP9—intracranial aneurysm	0.000112	0.000194	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NCF1—intracranial aneurysm	0.000112	0.000194	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—MMP2—intracranial aneurysm	0.00011	0.00019	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—EDNRA—intracranial aneurysm	0.00011	0.00019	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—NOS3—intracranial aneurysm	0.00011	0.00019	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—NOS3—intracranial aneurysm	0.00011	0.000189	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—AGER—intracranial aneurysm	0.000109	0.000187	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—SLC25A16—intracranial aneurysm	0.000108	0.000187	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—MMP9—intracranial aneurysm	0.000108	0.000187	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NCF1—intracranial aneurysm	0.000108	0.000186	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EDNRA—intracranial aneurysm	0.000108	0.000186	CbGpPWpGaD
Dasatinib—JAK2—Immune System—AGER—intracranial aneurysm	0.000107	0.000185	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—MMP9—intracranial aneurysm	0.000107	0.000184	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NCF1—intracranial aneurysm	0.000107	0.000184	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EDNRA—intracranial aneurysm	0.000106	0.000183	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NOS3—intracranial aneurysm	0.000103	0.000178	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EDNRA—intracranial aneurysm	0.000102	0.000176	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—NOS3—intracranial aneurysm	0.000101	0.000175	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000101	0.000174	CbGpPWpGaD
Dasatinib—LCK—Immune System—AGER—intracranial aneurysm	9.39e-05	0.000162	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NCF1—intracranial aneurysm	9.36e-05	0.000161	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ASAH1—intracranial aneurysm	9.3e-05	0.00016	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CCL2—intracranial aneurysm	9.2e-05	0.000159	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—MMP9—intracranial aneurysm	9.1e-05	0.000157	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EDNRA—intracranial aneurysm	8.83e-05	0.000152	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—MMP9—intracranial aneurysm	8.82e-05	0.000152	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CCL2—intracranial aneurysm	8.42e-05	0.000145	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CCL2—intracranial aneurysm	8.41e-05	0.000145	CbGpPWpGaD
Dasatinib—SRC—Immune System—AGER—intracranial aneurysm	8.31e-05	0.000143	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—MMP9—intracranial aneurysm	8.29e-05	0.000143	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NCF1—intracranial aneurysm	8.28e-05	0.000143	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—NOS3—intracranial aneurysm	8.2e-05	0.000141	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CCL2—intracranial aneurysm	8.11e-05	0.00014	CbGpPWpGaD
Dasatinib—KIT—Disease—NOS3—intracranial aneurysm	8.1e-05	0.00014	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EDNRA—intracranial aneurysm	7.82e-05	0.000135	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS3—intracranial aneurysm	7.66e-05	0.000132	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NOS3—intracranial aneurysm	7.5e-05	0.000129	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NOS3—intracranial aneurysm	7.23e-05	0.000125	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ASAH1—intracranial aneurysm	7.18e-05	0.000124	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CCL2—intracranial aneurysm	7.12e-05	0.000123	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS3—intracranial aneurysm	6.9e-05	0.000119	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS3—intracranial aneurysm	6.66e-05	0.000115	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—MMP9—intracranial aneurysm	6.58e-05	0.000113	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CCL2—intracranial aneurysm	6.36e-05	0.00011	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NOS3—intracranial aneurysm	6.35e-05	0.000109	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS3—intracranial aneurysm	6.33e-05	0.000109	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CCL2—intracranial aneurysm	6.02e-05	0.000104	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—MMP9—intracranial aneurysm	6.02e-05	0.000104	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—MMP9—intracranial aneurysm	5.8e-05	0.0001	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NOS3—intracranial aneurysm	5.67e-05	9.77e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS3—intracranial aneurysm	5.54e-05	9.55e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL2—intracranial aneurysm	5.43e-05	9.35e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NOS3—intracranial aneurysm	5.37e-05	9.25e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—intracranial aneurysm	5.31e-05	9.15e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—intracranial aneurysm	5.23e-05	9.01e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—intracranial aneurysm	5.09e-05	8.78e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—intracranial aneurysm	5.04e-05	8.68e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—intracranial aneurysm	4.97e-05	8.57e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—intracranial aneurysm	4.94e-05	8.52e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—intracranial aneurysm	4.91e-05	8.45e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—intracranial aneurysm	4.84e-05	8.33e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—intracranial aneurysm	4.73e-05	8.16e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—intracranial aneurysm	4.66e-05	8.03e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—intracranial aneurysm	4.55e-05	7.84e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—intracranial aneurysm	4.5e-05	7.75e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—intracranial aneurysm	4.49e-05	7.73e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—intracranial aneurysm	4.43e-05	7.63e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—intracranial aneurysm	4.35e-05	7.5e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—intracranial aneurysm	4.31e-05	7.42e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—intracranial aneurysm	3.88e-05	6.69e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—intracranial aneurysm	3.88e-05	6.69e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—intracranial aneurysm	3.85e-05	6.64e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—intracranial aneurysm	3.8e-05	6.55e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—intracranial aneurysm	3.74e-05	6.44e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—intracranial aneurysm	3.6e-05	6.2e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—intracranial aneurysm	3.55e-05	6.13e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—intracranial aneurysm	3.44e-05	5.92e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—intracranial aneurysm	3.22e-05	5.55e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—intracranial aneurysm	3.11e-05	5.37e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—intracranial aneurysm	3.04e-05	5.24e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—intracranial aneurysm	2.76e-05	4.75e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—intracranial aneurysm	2.43e-05	4.19e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—intracranial aneurysm	1.94e-05	3.34e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—intracranial aneurysm	1.5e-05	2.58e-05	CbGpPWpGaD
